Joel Greenblatt's CME Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 142,695 shares of CME Group Inc. (CME) worth $38.97 M, representing 0.14% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in CME, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2018, adding 61,196 shares. Largest reduction occurred in Q3 2018, reducing 56,119 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's CME Group (CME) Holding Value Over Time
Track share changes against reported price movement
Quarterly CME Group (CME) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -30,541 | Reduce 17.63% | 142,695 | $273.08 |
| Q3 2025 | +50,402 | Add 41.03% | 173,236 | $270.19 |
| Q2 2025 | +32,629 | Add 36.17% | 122,834 | $275.62 |
| Q1 2025 | +4,228 | Add 4.92% | 90,205 | $265.29 |
| Q4 2024 | +7,209 | Add 9.15% | 85,977 | $232.23 |
| Q3 2024 | -22,654 | Reduce 22.34% | 78,768 | $220.65 |
| Q2 2024 | +56,554 | Add 126.05% | 101,422 | $196.60 |
| Q1 2024 | +13,891 | Add 44.84% | 44,868 | $215.29 |
| Q4 2023 | +12,679 | Add 69.29% | 30,977 | $210.60 |
| Q3 2023 | -2,866 | Reduce 13.54% | 18,298 | $200.22 |
| Q2 2023 | -18,987 | Reduce 47.29% | 21,164 | $185.29 |
| Q1 2023 | +13,341 | Add 49.76% | 40,151 | $191.52 |
| Q4 2022 | +20,073 | Add 297.95% | 26,810 | $168.16 |
| Q3 2022 | -6,295 | Reduce 48.30% | 6,737 | $177.08 |
| Q2 2022 | -9,427 | Reduce 41.97% | 13,032 | $204.73 |
| Q1 2022 | +17,344 | Add 339.08% | 22,459 | $237.86 |
| Q4 2021 | -4,018 | Reduce 43.99% | 5,115 | $228.54 |
| Q3 2021 | +6,616 | Add 262.85% | 9,133 | $193.36 |
| Q2 2021 | +2,517 | New Buy | 2,517 | $212.55 |
| Q4 2020 | -2,664 | Sold Out | 0 | $0.00 |
| Q3 2020 | +411 | Add 18.24% | 2,664 | $167.42 |
| Q2 2020 | -4,161 | Reduce 64.87% | 2,253 | $162.45 |
| Q1 2020 | +3,923 | Add 157.49% | 6,414 | $172.90 |
| Q4 2019 | +2,491 | New Buy | 2,491 | $200.72 |
| Q2 2019 | -9,279 | Sold Out | 0 | $0.00 |
| Q1 2019 | +1,613 | Add 21.04% | 9,279 | $164.57 |
| Q4 2018 | -4,726 | Reduce 38.14% | 7,666 | $188.10 |
| Q3 2018 | -56,119 | Reduce 81.91% | 12,392 | $170.19 |
| Q2 2018 | +61,196 | Add 836.58% | 68,511 | $163.92 |
| Q1 2018 | +7,315 | New Buy | 7,315 | $161.72 |
| Q3 2017 | -37,922 | Sold Out | 0 | $0.00 |
| Q2 2017 | +19,217 | Add 102.74% | 37,922 | $125.23 |
| Q1 2017 | +11,487 | Add 159.14% | 18,705 | $118.79 |
| Q4 2016 | -10,932 | Reduce 60.23% | 7,218 | $115.41 |
| Q3 2016 | +10,014 | Add 123.08% | 18,150 | $104.52 |
| Q2 2016 | +8,136 | New Buy | 8,136 | $97.35 |
| Q3 2015 | -20,798 | Sold Out | 0 | $0.00 |
| Q2 2015 | +20,798 | New Buy | 20,798 | $93.04 |
| Q3 2014 | -4,716 | Sold Out | 0 | $0.00 |
| Q2 2014 | +4,716 | New Buy | 4,716 | $71.03 |
Joel Greenblatt's CME Group Investment FAQs
Joel Greenblatt first purchased CME Group Inc. (CME) in Q2 2014, acquiring 4,716 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held CME Group Inc. (CME) for 40 quarters since Q2 2014.
Joel Greenblatt's largest addition to CME Group Inc. (CME) was in Q2 2018, adding 68,511 shares worth $11.23 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 142,695 shares of CME Group Inc. (CME), valued at approximately $38.97 M.
As of the Q4 2025 filing, CME Group Inc. (CME) represents approximately 0.14% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in CME Group Inc. (CME) was 173,236 shares, as reported at the end of Q3 2025.